Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Shares, with no par value
-
Shares outstanding
-
50,973,571
-
Total 13F shares
-
1,727,190
-
Share change
-
+1,727,190
-
Total reported value
-
$4,433,025
-
Price per share
-
$2.58
-
Number of holders
-
8
-
Value change
-
+$4,433,018
-
Number of buys
-
8
Institutional Holders of EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value (EPRX) as of Q2 2024
As of 30 Jun 2024,
EUPRAXIA PHARMACEUTICALS INC. - Common Shares, with no par value (EPRX) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,727,190 shares.
The largest 8 holders included
SCOTIA CAPITAL INC., Royal Bank of Canada, BANK OF MONTREAL /CAN/, UBS Group AG, 180 WEALTH ADVISORS, LLC, JPMORGAN CHASE & CO, Federation des caisses Desjardins du Quebec, and TORONTO DOMINION BANK.
This page lists
8
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.